5-bromo-4-chloro-3-indolyl beta-galactoside has been researched along with Sensation Disorders in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chu, K; Jeong, SW; Jung, KH; Kang, L; Kim, M; Kim, SU; Lee, K; Lee, ST; Park, DK; Park, HK; Park, KI; Roh, JK | 1 |
1 other study(ies) available for 5-bromo-4-chloro-3-indolyl beta-galactoside and Sensation Disorders
| Article | Year |
|---|---|
Human neural stem cells improve sensorimotor deficits in the adult rat brain with experimental focal ischemia.
Topics: Animals; Behavior, Animal; Brain Ischemia; Cell Count; Cell Differentiation; Cells, Cultured; Disease Models, Animal; Embryo, Mammalian; Functional Laterality; Galactosides; Glial Fibrillary Acidic Protein; Humans; Immunohistochemistry; Indoles; Infarction, Middle Cerebral Artery; Male; Microscopy, Electron; Motor Activity; Neurons; Phosphopyruvate Hydratase; Psychomotor Performance; Rats; Rats, Sprague-Dawley; Recovery of Function; Rotarod Performance Test; Sensation Disorders; Stem Cell Transplantation; Time Factors; Vimentin | 2004 |